| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.02 |